Showing 66,021 - 66,040 results of 101,367 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( 5 ((c decrease) OR (a decrease)) ))', query time: 1.40s Refine Results
  1. 66021

    Image_6_Proteomic analysis reveals semaglutide impacts lipogenic protein expression in epididymal adipose tissue of obese mice.tif by Ruiyi Zhu (13963501)

    Published 2023
    “…Bioinformatics analysis showed a reduction of CD36, FABP5, ACSL, ACOX3, PLIN2, ANGPTL4, LPL, MGLL, AQP7, and PDK4 involved in the lipid metabolism in the Sema group accompanied by a decrease in visceral fat accumulation, blood lipids, and improvement in glucose intolerance.…”
  2. 66022

    Image_3_Proteomic analysis reveals semaglutide impacts lipogenic protein expression in epididymal adipose tissue of obese mice.tif by Ruiyi Zhu (13963501)

    Published 2023
    “…Bioinformatics analysis showed a reduction of CD36, FABP5, ACSL, ACOX3, PLIN2, ANGPTL4, LPL, MGLL, AQP7, and PDK4 involved in the lipid metabolism in the Sema group accompanied by a decrease in visceral fat accumulation, blood lipids, and improvement in glucose intolerance.…”
  3. 66023

    The probability of tumor nodule eradication increases with the increase of CTL number. by Claire Christophe (714134)

    Published 2015
    “…<p>(<i>A</i>) Empirical distribution of the number of early collisions (<i>N</i><sub><i>E</i></sub>) (CTL killing during the first 5 hours) in the CTL loss scenario (blue) and its respective mean number of collisions (cyan bar). …”
  4. 66024

    Table_3_Proteomic analysis reveals semaglutide impacts lipogenic protein expression in epididymal adipose tissue of obese mice.xlsx by Ruiyi Zhu (13963501)

    Published 2023
    “…Bioinformatics analysis showed a reduction of CD36, FABP5, ACSL, ACOX3, PLIN2, ANGPTL4, LPL, MGLL, AQP7, and PDK4 involved in the lipid metabolism in the Sema group accompanied by a decrease in visceral fat accumulation, blood lipids, and improvement in glucose intolerance.…”
  5. 66025

    Tension between hysteresis and biphasic dose-response. by Jeffrey V. Wong (168573)

    Published 2012
    “…Hysteresis is measured by calculating the path difference 24 hours after an increase in serum from 0.01% or after a decrease from 10%. Biphasic response is measured 36 hours after an increase in MYC synthesis (parameter ke<sub>MC</sub>; <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1002491#pcbi.1002491.s007" target="_blank">Text S1</a>). …”
  6. 66026

    Table_2_Incidence and Mortality Trends and Risk Prediction Nomogram for Extranodal Diffuse Large B-Cell Lymphoma: An Analysis of the Surveillance, Epidemiology, and End Results Dat... by Xuejiao Yin (5132441)

    Published 2019
    “…The incidence-based mortality trend of extranodal DLBCL had a similar pattern, with a decrease happening around 1993. …”
  7. 66027

    Single channel recording of ELIC. by Iwan Zimmermann (117942)

    Published 2011
    “…The errors are standard deviations (s.d.) obtained from fits to current amplitude histograms. (C) Current trace from a planar lipid bilayer containing at least two channels recorded at −100 mV in the presence of 2 mM cysteamine (recordings were filtered at 200 Hz). …”
  8. 66028

    Glibenclamide reduces the apoptosis and the loss of CVx36 in MIN6 cells exposed to Th1 cytokines. by Smaragda Lamprianou (3599570)

    Published 2016
    “…Such a decrease was not observed in cells exposed to 10 μM glibenclamide (solid bar). …”
  9. 66029

    Image_1_Proteomic analysis reveals semaglutide impacts lipogenic protein expression in epididymal adipose tissue of obese mice.tif by Ruiyi Zhu (13963501)

    Published 2023
    “…Bioinformatics analysis showed a reduction of CD36, FABP5, ACSL, ACOX3, PLIN2, ANGPTL4, LPL, MGLL, AQP7, and PDK4 involved in the lipid metabolism in the Sema group accompanied by a decrease in visceral fat accumulation, blood lipids, and improvement in glucose intolerance.…”
  10. 66030

    DtpT transports structurally diverse di-/tripeptides. by Imran Khan (109715)

    Published 2025
    “…Peptide transport is proton-coupled, leading to acidification of the lumen and a decrease in the pyranine fluorescence (ex. 460/ emm. 510). …”
  11. 66031

    Table_4_Proteomic analysis reveals semaglutide impacts lipogenic protein expression in epididymal adipose tissue of obese mice.xlsx by Ruiyi Zhu (13963501)

    Published 2023
    “…Bioinformatics analysis showed a reduction of CD36, FABP5, ACSL, ACOX3, PLIN2, ANGPTL4, LPL, MGLL, AQP7, and PDK4 involved in the lipid metabolism in the Sema group accompanied by a decrease in visceral fat accumulation, blood lipids, and improvement in glucose intolerance.…”
  12. 66032

    Table_2_Proteomic analysis reveals semaglutide impacts lipogenic protein expression in epididymal adipose tissue of obese mice.xlsx by Ruiyi Zhu (13963501)

    Published 2023
    “…Bioinformatics analysis showed a reduction of CD36, FABP5, ACSL, ACOX3, PLIN2, ANGPTL4, LPL, MGLL, AQP7, and PDK4 involved in the lipid metabolism in the Sema group accompanied by a decrease in visceral fat accumulation, blood lipids, and improvement in glucose intolerance.…”
  13. 66033

    Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease by Viktor Martyanov (396510)

    Published 2017
    “…Clinical response was defined as decrease of >5 or >20% from baseline in the modified Rodnan Skin Score (MRSS). …”
  14. 66034

    Community health workers for non-communicable diseases prevention and control in developing countries: Evidence and implications by Gursimer Jeet (535149)

    Published 2017
    “…The duration of the studies ranged from mean follow up of 4 months for some risk factors to 19 months, and primary responsibilities of health workers included health promotion, treatment adherence and follow ups. Only a single trial reported all-cause mortality. The pooled effect computed indicated an increase in tobacco cessation (RR: 2.0, 95%CI: 1.11, 3.58, moderate-quality evidence) and a decrease in systolic blood pressure ((MD: -4.80, 95% CI: -8.12, -1.49, I<sup>2</sup> = 93%, very low-quality evidence), diastolic blood pressure ((MD: -2.88, 95% CI: -5.65, -0.10, I<sup>2</sup> = 96%, very low-quality evidence)) and blood sugar levels (glycated haemoglobin MD: -0.83%, 95%CI: -1.25,-0.41). …”
  15. 66035

    Identification of Novel Single Nucleotide Polymorphisms in Inflammatory Genes as Risk Factors Associated with Trachomatous Trichiasis by Berna Atik (270071)

    Published 2008
    “…TT risk decreased 5 times [odds ratio = 0.2 (95% confidence interval 0.11.–0.33), <em>p</em> = 0.001] with the combination of TNFA (-308A), LTA (252A), VCAM1 (-1594C), SCYA 11 (23T) minor allele, and the combination of TNFA (-308A), IL9 (113M), IL1B (5′UTR-T), and VCAM1 (-1594C). …”
  16. 66036
  17. 66037

    Actionable Gene Expression-Based Patient Stratification for Molecular Targeted Therapy in Hepatocellular Carcinoma by Jung-Hee Kwon (421854)

    Published 2013
    “…Up-regulation of EGFR was observed at early stage and tended to gradually decrease toward late stages (BCLC stage A: 41.9%; B: 30.8%; C: 17.6%). …”
  18. 66038

    Image_2_Astrocytes Downregulate Inflammation in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome: Applicability to COVID-19.TIF by Michal Izrael (5343413)

    Published 2021
    “…Next, we tested the therapeutical potential of AstroRx cells in a lipopolysaccharide (LPS)-based ARDS mouse model by injecting AstroRx intravenously (i.v). …”
  19. 66039

    Image_1_Astrocytes Downregulate Inflammation in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome: Applicability to COVID-19.TIF by Michal Izrael (5343413)

    Published 2021
    “…Next, we tested the therapeutical potential of AstroRx cells in a lipopolysaccharide (LPS)-based ARDS mouse model by injecting AstroRx intravenously (i.v). …”
  20. 66040

    Image_3_Astrocytes Downregulate Inflammation in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome: Applicability to COVID-19.TIF by Michal Izrael (5343413)

    Published 2021
    “…Next, we tested the therapeutical potential of AstroRx cells in a lipopolysaccharide (LPS)-based ARDS mouse model by injecting AstroRx intravenously (i.v). …”